IRIS
FRANCESCHI, Valentina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.355
AS - Asia 3.154
EU - Europa 2.231
SA - Sud America 431
AF - Africa 159
Continente sconosciuto - Info sul continente non disponibili 134
OC - Oceania 4
Totale 10.468
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.190
SG - Singapore 1.002
CN - Cina 802
IT - Italia 651
VN - Vietnam 566
BR - Brasile 314
SE - Svezia 287
IE - Irlanda 255
HK - Hong Kong 226
FI - Finlandia 222
DE - Germania 194
BD - Bangladesh 183
FR - Francia 109
ZA - Sudafrica 101
GB - Regno Unito 100
CA - Canada 91
UA - Ucraina 82
RU - Federazione Russa 81
TR - Turchia 79
NL - Olanda 77
IN - India 67
AT - Austria 42
AR - Argentina 39
MX - Messico 36
KR - Corea 28
ES - Italia 27
ID - Indonesia 27
PH - Filippine 27
IQ - Iraq 25
BE - Belgio 24
JP - Giappone 23
EC - Ecuador 22
PL - Polonia 21
CO - Colombia 19
RO - Romania 17
VE - Venezuela 16
MA - Marocco 14
PK - Pakistan 12
IL - Israele 11
CI - Costa d'Avorio 10
LT - Lituania 10
PY - Paraguay 10
CR - Costa Rica 9
TH - Thailandia 9
SA - Arabia Saudita 8
JO - Giordania 7
TN - Tunisia 7
UZ - Uzbekistan 7
EG - Egitto 6
IR - Iran 6
MY - Malesia 6
SC - Seychelles 6
CZ - Repubblica Ceca 5
JM - Giamaica 5
AL - Albania 4
AZ - Azerbaigian 4
BZ - Belize 4
SK - Slovacchia (Repubblica Slovacca) 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CL - Cile 3
EE - Estonia 3
EU - Europa 3
HN - Honduras 3
HU - Ungheria 3
KE - Kenya 3
KW - Kuwait 3
KZ - Kazakistan 3
LB - Libano 3
PE - Perù 3
RS - Serbia 3
TW - Taiwan 3
UY - Uruguay 3
BB - Barbados 2
CG - Congo 2
CH - Svizzera 2
DK - Danimarca 2
DZ - Algeria 2
ET - Etiopia 2
GT - Guatemala 2
LK - Sri Lanka 2
MZ - Mozambico 2
NI - Nicaragua 2
NP - Nepal 2
OM - Oman 2
PA - Panama 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
Totale 10.328
Salva come PNG Salva come JPEG
Città #
Ashburn 599
Singapore 563
San Jose 424
Dallas 319
Santa Clara 298
Chandler 258
Dublin 252
Hong Kong 212
New York 181
Beijing 176
Council Bluffs 174
Ho Chi Minh City 173
Parma 160
Hanoi 127
Los Angeles 126
Boardman 117
Ann Arbor 105
Johannesburg 92
Jacksonville 91
Shanghai 90
Hefei 66
Dearborn 64
Munich 61
Lauterbourg 60
Milan 60
Buffalo 58
Izmir 51
Nanjing 49
Princeton 46
Chicago 42
Bologna 40
Toronto 38
São Paulo 37
Vienna 36
Wilmington 34
Rome 32
San Mateo 24
Brussels 23
Haiphong 23
Helsinki 23
Moscow 22
Bremen 21
Columbus 21
Da Nang 21
Düsseldorf 21
London 21
Orem 21
Phoenix 21
Hebei 20
Jakarta 20
Shenyang 20
Tokyo 20
Warsaw 20
Seattle 19
Kunming 18
Poggio Renatico 18
Turku 18
Modena 17
Atlanta 16
Montreal 16
Seoul 16
Jinan 15
Stockholm 15
Brooklyn 14
Marseille 14
Nanchang 14
Nuremberg 14
The Dalles 14
Tianjin 14
Des Moines 13
North Bergen 13
Washington 12
Biên Hòa 11
Changsha 11
Denver 11
Houston 11
Mexico City 11
Poplar 11
Pune 11
Rio de Janeiro 11
Abidjan 10
Amsterdam 10
Newark 10
Baghdad 9
Falls Church 9
Istanbul 9
Quito 9
Redondo Beach 9
Boston 8
Caracas 8
Casablanca 8
Frankfurt am Main 8
Guangzhou 8
Jiaxing 8
Las Piñas 8
Norwalk 8
Woodbridge 8
Ankara 7
Brasília 7
Can Tho 7
Totale 6.219
Salva come PNG Salva come JPEG
Nome #
Flavonoid-derived human phenyl-γ-valerolactone metabolites selectively detoxify amyloid-β oligomers and prevent memory impairment in a mouse model of Alzheimer's disease 285
Characterization of BoHV-4 ORF45 250
CANINE MALASSEZIA PACHYDERMATIS FIELD STRAINS SUSCEPTIBILITY TO AZOLES: A SURVEY 247
Cytokine expression, glucocorticoid and growth hormone changes after porcine reproductive and respiratory syndrome virus (PRRSV-1) infection in vaccinated and unvaccinated naturally exposed pigs 239
Chemico-Physical Properties of Some 1,1′-Bis-alkyl-2,2′-hexane-1,6-diyl-bispyridinium Chlorides Hydrogenated and Partially Fluorinated for Gene Delivery 237
A simplified sars-cov-2 pseudovirus neutralization assay 225
Gene-Delivery Ability of New Hydrogenated and Partially Fluorinated Gemini bispyridinium Surfactants with Six Methylene Spacers 219
Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients 210
Swine adipose stromal cells loaded with recombinant bovine herpesvirus 4 virions expressing a foreign antigen induce potent humoral immune responses in pigs. 209
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients 202
Identification of PSMB4 and PSMD4 as novel target genes correlated with 1q21 amplification in patients with smoldering myeloma and multiple myeloma 199
Arginine clustering on calix[4]arene macrocycles for improved cell penetration and DNA delivery 199
Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy 197
Comparative efficacy of selenoureido carbonic anhydrase inhibitors and azole antifungal drugs against clinical isolates of Malassezia pachydermatis 192
Myeloma Cells Deplete Bone Marrow Glutamine and Inhibit Osteoblast Differentiation Limiting Asparagine Availability 187
A Simple and Versatile Method for Ex Vivo Monitoring of Goat Vaginal Mucosa Transduction by Viral Vector Vaccines 178
Virally and physically transgenized equine adipose-derived stromal cells as a cargo for paracrine secreted factors 176
Bovine herpesvirus 4-based vector delivering a hybrid rat/human HER-2 oncoantigen efficiently protects mice from autochthonous Her-2+ mammary cancer 176
A dry powder formulation for peripheral lung delivery and absorption of an anti-SARS-CoV-2 ACE2 decoy polypeptide 172
Assessment and optimization of Theileria parva sporozoite full-length p67 antigen expression in mammalian cells 172
Bovine herpesvirus 4 glycoprotein B is indispensable for lytic replication and irreplaceable by VSVg. 168
A Structure-Activity Investigation on Modified Analogues of an Argininocalixarene Based Non-viral Gene Vector 168
Cyclodextrin- and calixarene-based polycationic amphiphiles as gene delivery systems: a structure–activity relationship study 168
Lower Rim Guanidinocalix[4]arenes: Macrocyclic Nonviral Vectors for Cell Transfection 164
In Vivo Image Analysis of BoHV-4-Based Vector in Mice 162
Immunization of knock-out α/β interferon receptor mice against lethal bluetongue infection with a BoHV-4-based vector expressing BTV-8 VP2 antigen. 161
In VivoImaging of Transiently Transgenized Mice with aBovine Interleukin 8 (CXCL8) Promoter/LuciferaseReporter Construct 161
Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines 160
Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4- based vaccine vector development 158
BoHV-4 immediate early 1 gene is a dispensable gene and its product is not a bone marrow stromal cell antigen 2 counteracting factor 157
Bovine herpesvirus 4 immediate early 2 (Rta) gene is an essential gene and is duplicated in bovine herpesvirus 4 isolate U. 156
BoHV-4-based vector delivering Ebola virus surface glycoprotein 156
Bovine herpesvirus-4-vectored delivery of nipah virus glycoproteins enhances T cell immunogenicity in pigs 155
Double immunization strategy with a BoHV-4-vectorialized secreted chimeric peptide BVDV-E2/BoHV-1-gD 154
Immunization With Bovine Herpesvirus-4-Based Vector Delivering PPRV-H Protein Protects Sheep From PPRV Challenge 154
Herpes simplex virus type 1 thymidine kinase-armed bovine herpesvirus type 4-based vector displays enhanced oncolytic properties in immunocompetent orthotopic syngenic mouse and rat glioma models. 149
Capacity to Elicit Cytotoxic CD8 T Cell Activity Against Mycobacterium avium subsp. paratuberculosis Is Retained in a Vaccine Candidate 35 kDa Peptide Modified for Expression in Mammalian Cells 147
Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease 146
Bovine herpesvirus-4-based vector delivering Peste des Petits Ruminants Virus hemagglutinin ORF induces both neutralizing antibodies and cytotoxic T cell responses 145
Persistency of Mesenchymal Stromal/Stem Cells in Lungs 144
Isolation and characterization of bovine herpesvirus 4 (BoHV-4) from a cow affected by post partum metritis and cloning of the genome as a bacterial artificial chromosome. 143
The Chemokine IL8 Is Up-Regulated in Bovine Endometrial Stromal Cells by the BoHV-4 IE2 Gene Product, ORF50/Rta: A Step Ahead Toward a Mechanism for BoHV-4 Induced Endometritis. 143
A recombinant bovine herpesvirus-4 vectored vaccine delivered via intranasal nebulization elicits viral neutralizing antibody titers in cattle 143
Efficient heterologous antigen gene delivery and expression by a replication-attenuated BoHV-4-based vaccine vector 143
Generation and characterization of the first immortalized alpaca cell line suitable for diagnostic and immunization studies. 139
Bovine Endometrial Stromal Cells Support Tumor Necrosis Factor Alpha-Induced Bovine Herpesvirus Type 4 Enhanced Replication 138
Humoral Immune Response in Immunized Sheep with Bovine Coronavirus Glycoproteins Delivered via an Adenoviral Vector 137
Integration of bovine herpesvirus 4 genome into cultured persistently infected host cell genome. 136
Clinical protection of goats against CpHV-1 induced genital disease with a BoHV-4-based vector expressing CpHV-1 gD. 135
Expression and secretion of Bluetongue virus serotype 8 (BTV-8)VP2 outer capsid protein by mammalian cells. 132
BoHV-4-based vector single heterologous antigen delivery protects STAT1(-/-) mice from monkeypoxvirus lethal challenge 131
Enlightened Mannhemia haemolytica lung inflammation in bovinized mice 129
Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral response 128
Risposta neuroendocrina ed evoluzione clinica in corso di infezione da PRRSV: effetto protettivo della vaccinazione 128
Characterization of caprine herpesvirus 1 (CpHV1) glycoprotein E and glycoprotein I ectodomains expressed in mammalian cells 128
p21Waf1/Cip1 as a molecular sensor for BoHV-4 replication 126
Induction of antihuman C-C chemokine receptor type 5 antibodies by a bovine herpesvirus type-4 based vector 124
Molecular and antigenic properties of mammalian cell-expressed theileria parva antigen Tp9 122
Vaccination of cattle with a virus vector vaccine against a major membrane protein of Mycobacterium avium subsp. paratuberculosis elicits CD8 cytotoxic T cells that kill intracellular bacteria 120
Cross-Reactive Immune Response of Bovine Coronavirus Spike Glycoprotein to SARS-CoV-2 Variants of Concern 107
Pygo2 Is Overexpressed in Myeloma Cells With 1q21 Amplification Being Involved in Carfilzomib Resistance 107
Immunotargeting of the xCT cystine/glutamate antiporter potentiates the efficacy of HER2-targeted immunotherapies in breast cancer 88
Calixaren as novel gene vector formulated within spray-dried inhalable powders 86
Generation, characterization, and application of caprine herpesvirus 1 secreted glycoprotein D 69
A Streamlined In Vitro mRNA Production Evaluation for mRNA-Based Vaccines and Therapeutics 61
PYGO2 is overexpressed in multiple myeloma patients with 1q21 amplification, driving plasma cell proliferation and cell cycle progression 46
Bovine herpesvirus 4 Immediate Early II gene is essential and can be duplicated 40
Oncolytic bovine herpesvirus type 1 induces immune microenvironment remodeling and enhances treatment responses in multiple myeloma 35
Totale 10.468
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.856
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022275 0 0 0 22 9 16 34 39 26 21 23 85
2022/20231.049 119 136 69 66 95 112 31 54 297 19 36 15
2023/2024604 37 41 13 17 59 165 59 52 16 25 43 77
2024/20251.600 40 64 109 95 170 191 81 73 225 122 157 273
2025/20264.629 364 405 614 441 603 274 372 155 588 339 315 159
2026/20271.037 192 221 260 364 0 0 0 0 0 0 0 0
Totale 10.468